Understanding Your Diagnosis and Pathology Reports

Diagnosing Epidermolysis Bullosa Acquisita (EBA) is a multi-step process because it can easily be mistaken for other autoimmune blistering diseases like bullous pemphigoid ^[1][2]. To confirm EBA, your medical team must perform specialized tests that look at both your skin tissue and your blood.

Understanding these reports empowers you to ensure your diagnostic workup is thorough and accurate, though it is important to remember no single test confirms the disease independently; they all provide clues that support a diagnosis when interpreted by an expert.

1. The Two-Biopsy Process (Routine Histology & DIF)

The first step is a skin biopsy. However, for a complete workup, the dermatologist often must take two separate specimens and handle them differently:

• Lesional Biopsy: Taken from a fresh blister edge and placed in formalin for routine microscopy (H&E) to look at general inflammation.
• Perilesional Biopsy: Taken from the healthy-looking skin immediately next to a blister, rather than from the blister itself, and placed in a special transport medium (like Michel’s solution) for Direct Immunofluorescence (DIF) ^[3]. Using the wrong site or container can make the result nondiagnostic.

The pathologist looks for a “linear” line of immune proteins (like IgG or C3) along the basement membrane zone (the border between skin layers) ^[3]. Crucially, they should look for the serration pattern:

• u-serrated pattern: This strongly supports the diagnosis of EBA ^[4]. The immune deposits look like small “u” shapes or “grass-like” structures ^[5]. This pattern is highly specific to EBA (though it can occasionally occur in bullous systemic lupus) ^[6].
• n-serrated pattern: This pattern is typically found in other diseases like bullous pemphigoid ^[5][7].

Note: Not every laboratory reports a serration pattern, so an absent or unreported u-pattern does not by itself mean the workup was inadequate.

2. Salt-Split Skin (IIF): The “Localization” Test

In this test, a sample of healthy human skin is chemically “split” with salt water to separate the layers ^[8]. Your blood serum is then applied to this split skin to see where your antibodies “stick.”

• Dermal Floor Binding: In EBA, the antibodies typically stick to the dermal floor (the bottom layer) because that is where Type VII collagen is located ^[9].
• Epidermal Roof Binding: In most other blistering diseases, antibodies stick to the epidermal roof (the top layer) ^[8].

Note: While “floor binding” strongly supports EBA, it is a localization clue, not a definitive diagnosis. It can also happen in subepidermal disorders like anti-p200 pemphigoid, so additional antigen-specific blood tests are needed for confirmation ^[8][10].

3. Antibody Blood Tests (ELISA and Immunoblotting)

These tests directly measure the amount of Type VII collagen (COL7) antibodies in your blood ^[3].

• ELISA: This is a test that provides a numerical score of your antibody levels. A positive result supports the diagnosis, but assays differ in sensitivity and specificity ^[11]. A positive result is not a substitute for clinicopathologic correlation, and the numerical result is assay-specific, not necessarily a measure of disease severity ^[12].
• Immunoblotting: This is a more specialized “mapping” test used if the ELISA results are unclear. It identifies the exact part of the collagen protein your immune system is attacking ^[11][12].

It is important to know that a negative blood test does not always rule out EBA. In some patients, the antibodies are stuck in the skin but are not circulating in high enough levels in the blood to be detected by standard tests ^[11][13].

Pathology Report Completeness Checklist

Use this checklist to review your medical records. If any of these are missing or unclear, it is a good topic for your next doctor’s visit.